Tracking the results of drug safety and efficacy
Inflammatory Myopathies in Children
Treatment options and recent research for juvenile dermatomyositis.
Drug Updates
Information on new approvals and medication safety.
Minerals, Mud, Martinis, and Methylprednisone
How the practice of rheumatology differs in America and Europe.
Coding Corner: Incident-To
A 65-year-old female Medicare patient with rheumatoid arthritis sees a nonphysician provider for a followup visit.
Systemic Juvenile Idiopathic Arthritis
Changing treatment paradigms in the biologic era
Coding Corner: May’s Coding Challenge
A 54-year-old female with rheumatoid arthritis is seen by the rheumatologist for a follow-up visit.
Treatment Patterns and Trends for Spondylarthropathies
Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk
Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.
Ethics Forum: The Ethical Pitfalls of Clinical Trials
Your patient is deciding whether to enroll in a clinical trial at your institution and wants your advice about whether to participate.